STOCKHOLDERS' EQUITY (Details - Warrants) - $ / shares |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Equity [Abstract] | |||
Warrants outstanding, beginning balance | 2,868,397 | 3,043,397 | |
Outstanding, Weighted Average Exercise Price | $ 0.01229 | $ 0.01229 | |
Weighted Average Remaining Contractual Life | 1 year 4 months 24 days | 2 years 4 months 24 days | 3 years 4 months 24 days |
Warrants issued | 0 | 0 | |
Issued, Weighted Average Exercise Price | $ 0 | $ 0 | |
Warrants expired/forfeited | 0 | (175,000) | |
Expired/Forfeited, Weighted Average Exercise Price | $ 0 | $ 0.20 | |
Warrants exercised | 0 | ||
Warrants expired/forfeited | 0 | 175,000 | |
Warrants outstanding, ending balance | 2,868,397 | 2,868,397 | 3,043,397 |
Outstanding Weighted Average Exercise Price | $ 0.00084 | $ 0.01229 | $ 0.01229 |
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|